MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease -
MedImmune licenses reverse genetics technology to Biken -
Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors -
Key Patent-Law Decisions' Impact to Be Covered by Wolf Greenfield Webinar -
PPD names new executive vice president and CMO -
UK smallcap opening - Norwood Immunology up on MedImmune deal -
Pinnacle signs stock purchase agreement with MedImmune -
ASTRAZENECA SAYS MEDIMMUNE CEO MOTT TO STEP DOWN -
Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune -
Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune -
DIREVO Receives Broad European Patent Protection for its Protease Optimization Platform -
DIREVO Receives Broad European Patent Protection for its Protease Optimization Platform -
Micromet and MedImmune initiate treatment in Phase II leukemia trial -
MedImmune's Brian Rosen Gets Montgomery County Chamber Chairmans Award -
Qualys to Host Its Security Conference -
MedImmune's motavizumab found effective in Phase III RSV trial -
MedImmune launches two new trials for treatment of asthma -
Sun Pharma launches generic Ethyol in the U.S. -
Genaera's partner MedImmune initiates Phase II asthma trial -
GENAERA: DEVELOPMENT PARTNER MEDIMMUNE INITIATES PHASE IIA TRIAL OF MEDI-528 -